Autor: |
Tanyanskiy, D. A., Maltseva, O. N., Trulioff, A. S., Saginbaev, U. R., Evstigneeva, P. E., Voronkina, I. V., Smagina, L. V., Ivanova, A. A., Dmitrieva, A. A., Ageeva, E. V., Sall, T. S., Denisenko, A. D. |
Předmět: |
|
Zdroj: |
Bulletin of Experimental Biology & Medicine; Dec2023, Vol. 176 Issue 2, p165-169, 5p |
Abstrakt: |
The influence of adiponectin, a protein secreted by adipocytes, on the activation of transendothelial LDL transport, the initial event of atherogenesis, was studied. The addition of adiponectin to the cultured endothelial hybridoma EA.hy926 cells did not affect both basal and TNF-stimulated transendothelial transport of LDL. In addition, adiponectin affects neither expression levels of CAV1, SCARB1, and ACVRL1 genes encoding proteins involved in transendothelial LDL transport, nor the MMP secretion by the EA.hy926cells. At the same time, adiponectin suppressed the TNF-stimulated IL-8 production and expression of the adhesion molecule gene ICAM1 in these cells. Thus, adiponectin reduces proinflammatory activation of EA.hy926 cells, which is not accompanied by changes in the transendothelial LDL transport. We speculate that anti-inflammatory action of adiponectin is the base for the influence of this adipokine on atherogenesis. [ABSTRACT FROM AUTHOR] |
Databáze: |
Complementary Index |
Externí odkaz: |
|